Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) for the treatment of ES-SCLC Serplulimab has now...
Cyient and Micware Navigations Forge Strategic Alliance to Shape the Future of Mobility
HYDERABAD, India, Feb. 5, 2025 /PRNewswire/ -- Cyient, a global Intelligent Engineering services company, announced that it entered into a memorandum of understanding with Micware Navigations, a leader in navigation and mobility services. As per the...
Harbour BioMed Receives NMPA IND Clearance for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 5, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody...
YCH Group and Sime Darby Property Form Strategic Collaboration to Explore Logistics Infrastructure
GEORGETOWN, Malaysia, Jan. 17, 2025 /PRNewswire/ -- On 16 January 2025, Singapore's leading logistics and supply chain company, YCH Group, has entered into a strategic partnership with Malaysia's premier property developer, Sime Darby Property...
Senaparib Approved by NMPA for 1L Maintenance Therapy in Ovarian Cancer
SHANGHAI, Jan. 17, 2025 /PRNewswire/ -- IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, is pleased to announce that Senaparib...
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today provides an update on its commercial and operational performance for the quarter ended 31 December...
Scintimun® Commercialization Partnership with Curium Pharma
MELBOURNE, Australia and LIÈGE, Belgium, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has entered into an agreement with Curium Pharma for the transfer of marketing...
DPC Dash - Domino's Pizza China Entered 13 New Cities with 14 New Stores, Creating a Festive Food Craze for Christmas and New Year
HONG KONG, Jan. 6, 2025 /PRNewswire/ -- DPC Dash – Domino's Pizza China ("DPC Dash" or the "Company") (1405.HK), Domino's Pizza's exclusive master franchisee in the China Mainland, the Hong Kong Special Administrative Region of China, and the Macau...
Globe Teleservices Signs International Voice Strategic Partnership with DITO Telecommunity
SINGAPORE, Dec. 17, 2024 /PRNewswire/ -- Globe Teleservices Pte. Ltd. (GTS), a leading global telecom solutions provider, has entered into an exclusive three-year agreement with DITO Telecommunity, the fastest-growing telecommunications provider in...
CNEY Entered into Warrant Inducement Agreements with Certain Holders
LISHUI, China, Dec. 5, 2024 /PRNewswire/ -- CN Energy Group. Inc. (NASDAQ: CNEY) ("CNEY" or the "Company") today announced that it entered into Warrant Inducement Agreements with certain holders (each, a "Holder") of the Company's existing ordinary...